Hubei Jumpcan Pharmaceutical (600566.SH) subsidiary obtained the registration certificate for lidocaine gel patch medication.
Jichuan Pharmaceutical (600566.SH) announced that its wholly-owned subsidiary Shaanxi Dongke Pharmaceutical Co., Ltd. (referred to as "".
Hubei Jumpcan Pharmaceutical (600566.SH) announced that its wholly-owned subsidiary Shaanxi Dongke Pharmaceutical Co., Ltd. ("Shaanxi Dongke") has received the "Drug Registration Certificate" for Lidocaine Gel Patch issued by the National Medical Products Administration. Lidocaine is an amide-type local anesthetic that works by inhibiting the ion channels required for the generation and conduction of nerve impulses, thus stabilizing the nerve cell membrane.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
